FFM

Fairmount Funds Management Portfolio holdings

AUM $772M
1-Year Est. Return 35.05%
This Quarter Est. Return
1 Year Est. Return
+35.05%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$165M
AUM Growth
-$107K
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
18
New
Increased
Reduced
Closed

Top Buys

1
+$12.5M
2
+$12.4M
3
+$11.2M
4
TRIL
Trillium Therapeutics Inc.
TRIL
+$7.34M
5
ACAD icon
Acadia Pharmaceuticals
ACAD
+$3.71M

Top Sells

1
+$4.13M
2
+$3.77M
3
+$2M
4
ARGX icon
argenx
ARGX
+$198K
5
TARA icon
Protara Therapeutics
TARA
+$140K

Sector Composition

1 Healthcare 95.55%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
1
$25.5M 15.47%
603,517
+87,729
2
$24M 14.58%
971,875
+505,000
3
$16.4M 9.92%
1,020,797
+31,798
4
$14.7M 8.92%
491,390
+37,500
5
$12.4M 7.51%
+1,340,395
6
$11.2M 6.76%
+189,598
7
$10.8M 6.55%
37,490
+10,716
8
$10.1M 6.12%
76,638
-1,500
9
$9.22M 5.59%
40,504
10
$8.74M 5.3%
169,949
+8,000
11
$7.95M 4.82%
178,662
+50,000
12
$7.34M 4.45%
+1,818,181
13
$3.49M 2.11%
43,586
+1,500
14
$3.1M 1.88%
200,125
+34,807
15
– –
-29,676
16
– –
-8,544
17
– –
-80,238
18
– –
-624,956